SCHEMBL15022102

SCHEMBL15022102

C[Si](C)(C)C#Cc1ccc(-n2cncc2-c2ccncc2)cc1

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ CYP11B1 P15538 1/20 0.39
▸ CYP11B2 P19099 1/20 0.39
▸ FLT3 P36888 3/20 0.35
▸ GABRA1 P14867 1/20 0.34
▸ GABRG2 P18507 1/20 0.34
▸ GABRB3 P28472 1/20 0.34
▸ GABRA5 P31644 1/20 0.34
▸ GABRA3 P34903 1/20 0.34
▸ GABRA2 P47869 1/20 0.34
▸ HSP90AA1 P07900 5/20 0.33
▸ HSP90AB1 P08238 5/20 0.33
▸ CRBN Q96SW2 2/20 0.32
▸ MAPK9 P45984 1/20 0.31
▸ MAPK10 P53779 1/20 0.31
▸ CYP3A4 P08684 1/20 0.31
▸ CYP2D6 P10635 1/20 0.31
▸ CYP2C9 P11712 1/20 0.31
▸ CYP19A1 P11511 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15022984 0.80 HDAC8 (0.46) CYP11B1CYP11B2FLT3HSP90AA1HSP90AB1
SCHEMBL13309560 0.77 FLT3 (0.55) CYP11B1CYP11B2FLT3HSP90AA1HSP90AB1
SCHEMBL15022987 0.77 MAPK9 (0.51) FLT3GABRA1GABRG2GABRB3GABRA5
SCHEMBL15022258 0.77 MAPK9 (0.51) FLT3GABRA1GABRG2GABRB3GABRA5
SCHEMBL3270166 0.74 ENPP2 (0.41) CYP11B1CYP11B2FLT3HSP90AA1HSP90AB1
SCHEMBL10773460 0.74 FLT3 (0.55) CYP11B1CYP11B2FLT3HSP90AA1HSP90AB1
SCHEMBL15022283 0.74 CYP11B1 (0.42) CYP11B1CYP11B2FLT3HSP90AA1HSP90AB1
SCHEMBL3274523 0.74 HSP90AA1 (0.52) CYP11B1CYP11B2HSP90AA1HSP90AB1CRBN
SCHEMBL15043369 0.73 GRM5 (0.42) CYP11B1CYP11B2CRBNMAPK9MAPK10
SCHEMBL15022086 0.71 MAPK9 (0.50) FLT3GABRA1GABRG2GABRB3GABRA5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130158031-A1 ALKYNE-BRIDGED HETERO-AROMATICS AND USES THEREOF SU ZHOU JING HONG BIOTECH CO., LTD. (CN) 2013-06-20 — — US disclosed
US-20130158031-A1 ALKYNE-BRIDGED HETERO-AROMATICS AND USES THEREOF SU ZHOU JING HONG BIOTECH CO., LTD. (CN) 2013-06-20 — — US disclosed
US-20130158031-A1 ALKYNE-BRIDGED HETERO-AROMATICS AND USES THEREOF SU ZHOU JING HONG BIOTECH CO., LTD. (CN) 2013-06-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130158031-A1 ALKYNE-BRIDGED HETERO-AROMATICS AND USES THEREOF CHRNA10, ATXN10, SCN10A CYP11B1 564/4885CYP11B2 865/4885FLT3 2887/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback